Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome
Amedeo Lonardo, Stefano Ballestri, Giulio Marchesini, et al.
Digestive and Liver Disease (2014) Vol. 47, Iss. 3, pp. 181-190
Open Access | Times Cited: 630

Showing 1-25 of 630 citing articles:

NAFLD and diabetes mellitus
Herbert Tilg, Alexander R. Moschen, Michael Roden
Nature Reviews Gastroenterology & Hepatology (2016) Vol. 14, Iss. 1, pp. 32-42
Closed Access | Times Cited: 846
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
Judith Aron‐Wisnewsky, Chloé Vigliotti, Julia J. Witjes, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 5, pp. 279-297
Open Access | Times Cited: 774
Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009
Zobair M. Younossi, Munkhzul Otgonsuren, Linda Henry, et al.
Hepatology (2015) Vol. 62, Iss. 6, pp. 1723-1730
Closed Access | Times Cited: 738
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta‐analysis
Stefano Ballestri, Stefano Zona, Giovanni Targher, et al.
Journal of Gastroenterology and Hepatology (2015) Vol. 31, Iss. 5, pp. 936-944
Closed Access | Times Cited: 645
Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
Amedeo Lonardo, Fabio Nascimbeni, Alessandro Mantovani, et al.
Journal of Hepatology (2017) Vol. 68, Iss. 2, pp. 335-352
Closed Access | Times Cited: 625
Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
Sven Francque, Denise van der Graaff, Wilhelmus J. Kwanten
Journal of Hepatology (2016) Vol. 65, Iss. 2, pp. 425-443
Open Access | Times Cited: 482
Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups
Amedeo Lonardo, Stefano Bellentani, Curtis K. Argo, et al.
Digestive and Liver Disease (2015) Vol. 47, Iss. 12, pp. 997-1006
Open Access | Times Cited: 414
Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Mengwei Li, Xiaowei Chi, Ying Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 405
Niclosamide: Beyond an antihelminthic drug
Wei Chen, Robert A. Mook, Richard T. Premont, et al.
Cellular Signalling (2017) Vol. 41, pp. 89-96
Open Access | Times Cited: 390
An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans
Adil Mardinoğlu, Hao Wu, Elias Björnson, et al.
Cell Metabolism (2018) Vol. 27, Iss. 3, pp. 559-571.e5
Open Access | Times Cited: 390
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions
Amedeo Lonardo, Fabio Nascimbeni, Giovanni Targher, et al.
Digestive and Liver Disease (2017) Vol. 49, Iss. 5, pp. 471-483
Open Access | Times Cited: 288
Diet, weight loss, and liver health in nonalcoholic fatty liver disease: Pathophysiology, evidence, and practice
Giulio Marchesini, Salvatore Petta, Riccardo Dalle Grave
Hepatology (2015) Vol. 63, Iss. 6, pp. 2032-2043
Open Access | Times Cited: 276
A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease
Zhonge Chen, Rong Yu, Ying Xiong, et al.
Lipids in Health and Disease (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 263
Nonalcoholic Fatty Liver Disease
Rotonya M. Carr, Amanke Oranu, Vandana Khungar
Gastroenterology Clinics of North America (2016) Vol. 45, Iss. 4, pp. 639-652
Open Access | Times Cited: 258
PPARs: Regulators of Metabolism and As Therapeutic Targets in Cardiovascular disease. Part II: PPAR-β/δ and PPAR-γ
Lu Han, Wen‐Jun Shen, Stefanie Bittner, et al.
Future Cardiology (2017) Vol. 13, Iss. 3, pp. 279-296
Open Access | Times Cited: 226
Transient elastography (FibroScan®) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?
Ivana Mikolašević, Lidija Orlić, Neven Franjić, et al.
World Journal of Gastroenterology (2016) Vol. 22, Iss. 32, pp. 7236-7236
Open Access | Times Cited: 225
Non-alcoholic fatty liver disease and risk of cardiovascular disease
Amedeo Lonardo, Silvia Sookoian, Carlos J. Pirola, et al.
Metabolism (2015) Vol. 65, Iss. 8, pp. 1136-1150
Open Access | Times Cited: 218
Fatty Acids Consumption: The Role Metabolic Aspects Involved in Obesity and Its Associated Disorders
Priscila Silva Figueiredo, Aline Carla Inada, Gabriela Marcelino, et al.
Nutrients (2017) Vol. 9, Iss. 10, pp. 1158-1158
Open Access | Times Cited: 212
Bi-directional analysis between fatty liver and cardiovascular disease risk factors
Jiantao Ma, Shih‐Jen Hwang, Alison Pedley, et al.
Journal of Hepatology (2016) Vol. 66, Iss. 2, pp. 390-397
Open Access | Times Cited: 200
Review on Clinical Trials of Black Seed (Nigella sativa ) and Its Active Constituent, Thymoquinone
Hossein Hosseinzadeh, Alireza Tavakkoli, Vahid Mahdian, et al.
Journal of pharmacopuncture (2017) Vol. 20, Iss. 3, pp. 179-193
Open Access | Times Cited: 197
Fatty Acids and NLRP3 Inflammasome–Mediated Inflammation in Metabolic Tissues
Jessica C. Ralston, Claire L. Lyons, Elaine Kennedy, et al.
Annual Review of Nutrition (2017) Vol. 37, Iss. 1, pp. 77-102
Closed Access | Times Cited: 192
Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease
Yoosoo Chang, Hyun Suk Jung, Juhee Cho, et al.
The American Journal of Gastroenterology (2016) Vol. 111, Iss. 8, pp. 1133-1140
Closed Access | Times Cited: 191
Nonalcoholic fatty liver disease: Evolving paradigms
Amedeo Lonardo, Fabio Nascimbeni, Mauro Maurantonio, et al.
World Journal of Gastroenterology (2017) Vol. 23, Iss. 36, pp. 6571-6592
Open Access | Times Cited: 182
Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications
Claudio Tana, Stefano Ballestri, Fabrizio Ricci, et al.
International Journal of Environmental Research and Public Health (2019) Vol. 16, Iss. 17, pp. 3104-3104
Open Access | Times Cited: 172
Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: A systematic review and meta-analysis of observational studies
Stefano Marventano, Federico Salomone, Justyna Godos, et al.
Clinical Nutrition (2016) Vol. 35, Iss. 6, pp. 1269-1281
Closed Access | Times Cited: 169
Page 1 - Next Page

Scroll to top